Global Monoclonal Antibodies Product Market Research Report 2022
SKU ID : QYR-21415614 | Publishing Date : 03-Aug-2022 | No. of pages : 83
Detailed TOC of Global Monoclonal Antibodies Product Market Research Report 2022
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibodies Product Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Cancer
1.2.3 Autoimmune Diseases
1.2.4 Infection
1.2.5 Hematological Diseases
1.2.6 Others
1.3 Market by Application
1.3.1 Global Monoclonal Antibodies Product Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Academic Institutes
1.3.4 Clinics
1.3.5 Diagnostic Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibodies Product Market Perspective (2017-2028)
2.2 Monoclonal Antibodies Product Growth Trends by Region
2.2.1 Monoclonal Antibodies Product Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Monoclonal Antibodies Product Historic Market Size by Region (2017-2022)
2.2.3 Monoclonal Antibodies Product Forecasted Market Size by Region (2023-2028)
2.3 Monoclonal Antibodies Product Market Dynamics
2.3.1 Monoclonal Antibodies Product Industry Trends
2.3.2 Monoclonal Antibodies Product Market Drivers
2.3.3 Monoclonal Antibodies Product Market Challenges
2.3.4 Monoclonal Antibodies Product Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibodies Product Players by Revenue
3.1.1 Global Top Monoclonal Antibodies Product Players by Revenue (2017-2022)
3.1.2 Global Monoclonal Antibodies Product Revenue Market Share by Players (2017-2022)
3.2 Global Monoclonal Antibodies Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Monoclonal Antibodies Product Revenue
3.4 Global Monoclonal Antibodies Product Market Concentration Ratio
3.4.1 Global Monoclonal Antibodies Product Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibodies Product Revenue in 2021
3.5 Monoclonal Antibodies Product Key Players Head office and Area Served
3.6 Key Players Monoclonal Antibodies Product Product Solution and Service
3.7 Date of Enter into Monoclonal Antibodies Product Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibodies Product Breakdown Data by Type
4.1 Global Monoclonal Antibodies Product Historic Market Size by Type (2017-2022)
4.2 Global Monoclonal Antibodies Product Forecasted Market Size by Type (2023-2028)
5 Monoclonal Antibodies Product Breakdown Data by Application
5.1 Global Monoclonal Antibodies Product Historic Market Size by Application (2017-2022)
5.2 Global Monoclonal Antibodies Product Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Monoclonal Antibodies Product Market Size (2017-2028)
6.2 North America Monoclonal Antibodies Product Market Size by Country (2017-2022)
6.3 North America Monoclonal Antibodies Product Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Monoclonal Antibodies Product Market Size (2017-2028)
7.2 Europe Monoclonal Antibodies Product Market Size by Country (2017-2022)
7.3 Europe Monoclonal Antibodies Product Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibodies Product Market Size (2017-2028)
8.2 Asia-Pacific Monoclonal Antibodies Product Market Size by Country (2017-2022)
8.3 Asia-Pacific Monoclonal Antibodies Product Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Monoclonal Antibodies Product Market Size (2017-2028)
9.2 Latin America Monoclonal Antibodies Product Market Size by Country (2017-2022)
9.3 Latin America Monoclonal Antibodies Product Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibodies Product Market Size (2017-2028)
10.2 Middle East & Africa Monoclonal Antibodies Product Market Size by Country (2017-2022)
10.3 Middle East & Africa Monoclonal Antibodies Product Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Monoclonal Antibodies Product Introduction
11.1.4 AbbVie Revenue in Monoclonal Antibodies Product Business (2017-2022)
11.1.5 AbbVie Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Monoclonal Antibodies Product Introduction
11.2.4 Roche Revenue in Monoclonal Antibodies Product Business (2017-2022)
11.2.5 Roche Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Monoclonal Antibodies Product Introduction
11.3.4 Johnson & Johnson Revenue in Monoclonal Antibodies Product Business (2017-2022)
11.3.5 Johnson & Johnson Recent Development
11.4 Amgen
11.4.1 Amgen Company Detail
11.4.2 Amgen Business Overview
11.4.3 Amgen Monoclonal Antibodies Product Introduction
11.4.4 Amgen Revenue in Monoclonal Antibodies Product Business (2017-2022)
11.4.5 Amgen Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Monoclonal Antibodies Product Introduction
11.5.4 Merck Revenue in Monoclonal Antibodies Product Business (2017-2022)
11.5.5 Merck Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Monoclonal Antibodies Product Introduction
11.6.4 Pfizer Revenue in Monoclonal Antibodies Product Business (2017-2022)
11.6.5 Pfizer Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Monoclonal Antibodies Product Introduction
11.7.4 Novartis Revenue in Monoclonal Antibodies Product Business (2017-2022)
11.7.5 Novartis Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Detail
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Monoclonal Antibodies Product Introduction
11.8.4 Eli Lilly Revenue in Monoclonal Antibodies Product Business (2017-2022)
11.8.5 Eli Lilly Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Detail
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Monoclonal Antibodies Product Introduction
11.9.4 GlaxoSmithKline Revenue in Monoclonal Antibodies Product Business (2017-2022)
11.9.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Monoclonal Antibodies Product Market Research Report 2022
List of TablesTable 1. Global Monoclonal Antibodies Product Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Cancer
Table 3. Key Players of Autoimmune Diseases
Table 4. Key Players of Infection
Table 5. Key Players of Hematological Diseases
Table 6. Key Players of Others
Table 7. Global Monoclonal Antibodies Product Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Monoclonal Antibodies Product Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Monoclonal Antibodies Product Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Monoclonal Antibodies Product Market Share by Region (2017-2022)
Table 11. Global Monoclonal Antibodies Product Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Monoclonal Antibodies Product Market Share by Region (2023-2028)
Table 13. Monoclonal Antibodies Product Market Trends
Table 14. Monoclonal Antibodies Product Market Drivers
Table 15. Monoclonal Antibodies Product Market Challenges
Table 16. Monoclonal Antibodies Product Market Restraints
Table 17. Global Monoclonal Antibodies Product Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Monoclonal Antibodies Product Market Share by Players (2017-2022)
Table 19. Global Top Monoclonal Antibodies Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibodies Product as of 2021)
Table 20. Ranking of Global Top Monoclonal Antibodies Product Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Monoclonal Antibodies Product Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Monoclonal Antibodies Product Product Solution and Service
Table 24. Date of Enter into Monoclonal Antibodies Product Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Monoclonal Antibodies Product Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Monoclonal Antibodies Product Revenue Market Share by Type (2017-2022)
Table 28. Global Monoclonal Antibodies Product Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Monoclonal Antibodies Product Revenue Market Share by Type (2023-2028)
Table 30. Global Monoclonal Antibodies Product Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Monoclonal Antibodies Product Revenue Market Share by Application (2017-2022)
Table 32. Global Monoclonal Antibodies Product Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Monoclonal Antibodies Product Revenue Market Share by Application (2023-2028)
Table 34. North America Monoclonal Antibodies Product Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Monoclonal Antibodies Product Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Monoclonal Antibodies Product Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Monoclonal Antibodies Product Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Monoclonal Antibodies Product Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Monoclonal Antibodies Product Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Monoclonal Antibodies Product Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Monoclonal Antibodies Product Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Monoclonal Antibodies Product Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Monoclonal Antibodies Product Market Size by Country (2023-2028) & (US$ Million)
Table 44. AbbVie Company Detail
Table 45. AbbVie Business Overview
Table 46. AbbVie Monoclonal Antibodies Product Product
Table 47. AbbVie Revenue in Monoclonal Antibodies Product Business (2017-2022) & (US$ Million)
Table 48. AbbVie Recent Development
Table 49. Roche Company Detail
Table 50. Roche Business Overview
Table 51. Roche Monoclonal Antibodies Product Product
Table 52. Roche Revenue in Monoclonal Antibodies Product Business (2017-2022) & (US$ Million)
Table 53. Roche Recent Development
Table 54. Johnson & Johnson Company Detail
Table 55. Johnson & Johnson Business Overview
Table 56. Johnson & Johnson Monoclonal Antibodies Product Product
Table 57. Johnson & Johnson Revenue in Monoclonal Antibodies Product Business (2017-2022) & (US$ Million)
Table 58. Johnson & Johnson Recent Development
Table 59. Amgen Company Detail
Table 60. Amgen Business Overview
Table 61. Amgen Monoclonal Antibodies Product Product
Table 62. Amgen Revenue in Monoclonal Antibodies Product Business (2017-2022) & (US$ Million)
Table 63. Amgen Recent Development
Table 64. Merck Company Detail
Table 65. Merck Business Overview
Table 66. Merck Monoclonal Antibodies Product Product
Table 67. Merck Revenue in Monoclonal Antibodies Product Business (2017-2022) & (US$ Million)
Table 68. Merck Recent Development
Table 69. Pfizer Company Detail
Table 70. Pfizer Business Overview
Table 71. Pfizer Monoclonal Antibodies Product Product
Table 72. Pfizer Revenue in Monoclonal Antibodies Product Business (2017-2022) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. Novartis Company Detail
Table 75. Novartis Business Overview
Table 76. Novartis Monoclonal Antibodies Product Product
Table 77. Novartis Revenue in Monoclonal Antibodies Product Business (2017-2022) & (US$ Million)
Table 78. Novartis Recent Development
Table 79. Eli Lilly Company Detail
Table 80. Eli Lilly Business Overview
Table 81. Eli Lilly Monoclonal Antibodies Product Product
Table 82. Eli Lilly Revenue in Monoclonal Antibodies Product Business (2017-2022) & (US$ Million)
Table 83. Eli Lilly Recent Development
Table 84. GlaxoSmithKline Company Detail
Table 85. GlaxoSmithKline Business Overview
Table 86. GlaxoSmithKline Monoclonal Antibodies Product Product
Table 87. GlaxoSmithKline Revenue in Monoclonal Antibodies Product Business (2017-2022) & (US$ Million)
Table 88. GlaxoSmithKline Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal Antibodies Product Market Share by Type: 2021 VS 2028
Figure 2. Cancer Features
Figure 3. Autoimmune Diseases Features
Figure 4. Infection Features
Figure 5. Hematological Diseases Features
Figure 6. Others Features
Figure 7. Global Monoclonal Antibodies Product Market Share by Application in 2021 & 2028
Figure 8. Hospitals Case Studies
Figure 9. Academic Institutes Case Studies
Figure 10. Clinics Case Studies
Figure 11. Diagnostic Laboratories Case Studies
Figure 12. Monoclonal Antibodies Product Report Years Considered
Figure 13. Global Monoclonal Antibodies Product Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Monoclonal Antibodies Product Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Monoclonal Antibodies Product Market Share by Region: 2021 VS 2028
Figure 16. Global Monoclonal Antibodies Product Market Share by Players in 2021
Figure 17. Global Top Monoclonal Antibodies Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibodies Product as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Monoclonal Antibodies Product Revenue in 2021
Figure 19. North America Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. North America Monoclonal Antibodies Product Market Share by Country (2017-2028)
Figure 21. United States Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Monoclonal Antibodies Product Market Share by Country (2017-2028)
Figure 25. Germany Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Monoclonal Antibodies Product Market Share by Region (2017-2028)
Figure 33. China Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Japan Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. South Korea Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Southeast Asia Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. India Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Australia Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Monoclonal Antibodies Product Market Share by Country (2017-2028)
Figure 41. Mexico Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Brazil Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Monoclonal Antibodies Product Market Share by Country (2017-2028)
Figure 45. Turkey Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Saudi Arabia Monoclonal Antibodies Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. AbbVie Revenue Growth Rate in Monoclonal Antibodies Product Business (2017-2022)
Figure 48. Roche Revenue Growth Rate in Monoclonal Antibodies Product Business (2017-2022)
Figure 49. Johnson & Johnson Revenue Growth Rate in Monoclonal Antibodies Product Business (2017-2022)
Figure 50. Amgen Revenue Growth Rate in Monoclonal Antibodies Product Business (2017-2022)
Figure 51. Merck Revenue Growth Rate in Monoclonal Antibodies Product Business (2017-2022)
Figure 52. Pfizer Revenue Growth Rate in Monoclonal Antibodies Product Business (2017-2022)
Figure 53. Novartis Revenue Growth Rate in Monoclonal Antibodies Product Business (2017-2022)
Figure 54. Eli Lilly Revenue Growth Rate in Monoclonal Antibodies Product Business (2017-2022)
Figure 55. GlaxoSmithKline Revenue Growth Rate in Monoclonal Antibodies Product Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Keyplayers in Global Monoclonal Antibodies Product Market Research Report 2022
AbbVieRoche
Johnson & Johnson
Amgen
Merck
Pfizer
Novartis
Eli Lilly
GlaxoSmithKline